Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) Director Howard Rubin sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $35.23, for a total transaction of $1,056,900.00. Following the sale, the director owned 203,288 shares of the company’s stock, valued at $7,161,836.24. This represents a 12.86% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Trupanion Trading Down 0.2%
Shares of Trupanion stock opened at $34.30 on Friday. The company has a fifty day simple moving average of $27.61 and a 200-day simple moving average of $26.73. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $39.61. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.24. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of 56.23, a PEG ratio of 1.59 and a beta of 1.27.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, November 5th. The financial services provider reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. The firm had revenue of $405.59 million for the quarter, compared to the consensus estimate of $402.53 million. During the same period last year, the firm posted $0.13 EPS. On average, equities analysts forecast that Trupanion, Inc. will post 0.68 EPS for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Several institutional investors and hedge funds have recently added to or reduced their stakes in TRUP. Bank of New York Mellon Corp acquired a new stake in shares of Trupanion in the 2nd quarter valued at approximately $4,631,000. Bank of America Corp DE purchased a new stake in shares of Trupanion in the second quarter valued at approximately $14,262,000. Renaissancere Holdings Ltd. purchased a new stake in shares of Trupanion in the second quarter valued at approximately $6,514,510. Legal & General Group Plc purchased a new stake in shares of Trupanion in the second quarter valued at approximately $1,938,000. Finally, GSA Capital Partners LLP acquired a new position in Trupanion during the second quarter worth $1,394,000.
Analysts Set New Price Targets
Several brokerages have issued reports on TRUP. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Stifel Nicolaus lifted their target price on Trupanion from $29.00 to $34.00 and gave the company a “hold” rating in a research note on Monday. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Cantor Fitzgerald upped their price objective on shares of Trupanion from $30.00 to $33.00 and gave the stock a “neutral” rating in a research report on Monday. Finally, Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, September 29th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Trupanion has a consensus rating of “Hold” and a consensus target price of $40.00.
Check Out Our Latest Report on Trupanion
Trupanion News Summary
These are some of the TRUP news items that stood out recently:
- Positive Sentiment: Two analyst headlines say Cantor Fitzgerald and Stifel Nicolaus expect Trupanion’s stock to rise, offering support for the bullish outlook. The articles provided do not include target prices or further rationale. Cantor Fitzgerald analyst article Stifel Nicolaus analyst article
- Positive Sentiment: Trupanion was recognized among Canada’s best companies for customer service by Newsweek, a reputational positive that may support its brand. Newsweek customer-service recognition
- Negative Sentiment: Three insiders disclosed sales: Director Howard Rubin sold 30,000 shares, Director Murray Low sold 6,537, and CEO Margaret Tooth sold 2,000. These transactions could weigh on sentiment, though each retained a substantial holding; Tooth’s sale was made under a pre-arranged Rule 10b5-1 plan. Rubin SEC filing Low SEC filing Tooth SEC filing
About Trupanion
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
Featured Stories
- Five stocks we like better than Trupanion
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
